• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清神经丝轻链水平可能是肌萎缩侧索硬化症中运动神经元损伤的一个标志物。

Serum Neurofilament Light Chain Levels May Be a Marker of Lower Motor Neuron Damage in Amyotrophic Lateral Sclerosis.

作者信息

Zhang Linjing, Ji Tuo, Wu Chujun, Zhang Shuo, Tang Lu, Zhang Nan, Liu Xiangyi, Fan Dongsheng

机构信息

Department of Neurology, Peking University Third Hospital, Beijing, China.

Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China.

出版信息

Front Neurol. 2022 Feb 23;13:833507. doi: 10.3389/fneur.2022.833507. eCollection 2022.

DOI:10.3389/fneur.2022.833507
PMID:35280276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8905596/
Abstract

Objectives The aims of this study were to investigate whether serum neurofilament light chain (NfL) levels were correlated with the severity of the axonal degeneration of lower motor neurons (LMNs) in the early symptomatic phase of amyotrophic lateral sclerosis (ALS). Methods In this prospective study, the serum samples used for NfL measurement were obtained from 103 sporadic ALS outpatients within 2 years of disease duration. The severity of axonal degeneration was assessed by assessing the decrease in the compound muscle action potentials (CMAPs) within a 1-month interval from serum sampling. Results The NfL levels showed a significant positive correlation with the relative score as a proxy for the axonal damage of LMNs in patients with ALS (coefficient: 0.264, = 0.009). Furthermore, this correlation became stronger (coefficient: 0.582, = 0.037) when estimated only among patients with disease subtypes that involve only LMNs, that is, patients with flail arm or leg syndrome (FAS or FLS). The levels of NfL increased with the severity of axonal damage of LMNs (F = 6.694, = 0.0001). Conclusions Serum NfL levels mirrored the severity of the axonal degeneration of LMNs, particularly in patients with signs of predominant LMN involvement. These results may have a profound effect on the selection of patients and the monitoring of treatment efficacy in future disease-modifying clinical trials.

摘要

目的 本研究旨在调查在肌萎缩侧索硬化症(ALS)早期症状阶段,血清神经丝轻链(NfL)水平是否与下运动神经元(LMNs)轴突退变的严重程度相关。方法 在这项前瞻性研究中,用于测量NfL的血清样本取自103例疾病病程在2年以内的散发性ALS门诊患者。通过评估血清采样后1个月内复合肌肉动作电位(CMAPs)的下降情况来评估轴突退变的严重程度。结果 NfL水平与作为ALS患者LMNs轴突损伤替代指标的相对评分呈显著正相关(系数:0.264,P = 0.009)。此外,仅在仅累及LMNs的疾病亚型患者中进行评估时,即连枷臂或连枷腿综合征(FAS或FLS)患者中,这种相关性更强(系数:0.582,P = 0.037)。NfL水平随着LMNs轴突损伤严重程度的增加而升高(F = 6.694,P = 0.0001)。结论 血清NfL水平反映了LMNs轴突退变的严重程度,特别是在主要表现为LMNs受累迹象的患者中。这些结果可能对未来疾病修饰临床试验中的患者选择和治疗疗效监测产生深远影响。

相似文献

1
Serum Neurofilament Light Chain Levels May Be a Marker of Lower Motor Neuron Damage in Amyotrophic Lateral Sclerosis.血清神经丝轻链水平可能是肌萎缩侧索硬化症中运动神经元损伤的一个标志物。
Front Neurol. 2022 Feb 23;13:833507. doi: 10.3389/fneur.2022.833507. eCollection 2022.
2
Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.血清神经丝轻链水平作为肌萎缩侧索硬化症患者上运动神经元退变的标志物。
Neuropathol Appl Neurobiol. 2019 Apr;45(3):291-304. doi: 10.1111/nan.12511. Epub 2018 Jul 18.
3
Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis.肌萎缩侧索硬化症血清神经丝轻链水平的表型相关性
Front Aging Neurosci. 2023 Mar 15;15:1132808. doi: 10.3389/fnagi.2023.1132808. eCollection 2023.
4
Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者血清和脑脊液中的神经丝标记物。
J Cell Mol Med. 2022 Jan;26(2):583-587. doi: 10.1111/jcmm.17100. Epub 2021 Dec 6.
5
Multifocal motor neuropathy as a mimic of amyotrophic lateral sclerosis: Serum neurofilament light chain as a reliable diagnostic biomarker.多灶性运动神经病酷似肌萎缩侧索硬化症:血清神经丝轻链作为可靠的诊断生物标志物。
Muscle Nerve. 2024 Apr;69(4):422-427. doi: 10.1002/mus.28054. Epub 2024 Feb 9.
6
Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.神经丝轻链作为肌萎缩侧索硬化症和额颞叶痴呆的生物标志物。
Front Neurosci. 2021 Jun 21;15:679199. doi: 10.3389/fnins.2021.679199. eCollection 2021.
7
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.CSF 生物标志物在肌萎缩侧索硬化症中的神经退行性变和神经炎症的诊断预后价值及电生理学相关性。
J Neurol. 2020 Jun;267(6):1699-1708. doi: 10.1007/s00415-020-09761-z. Epub 2020 Feb 25.
8
CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration.原发性进行性多发性硬化症患者脑脊液中神经丝轻链水平:轴突神经变性的迹象
Front Neurol. 2018 Dec 14;9:1037. doi: 10.3389/fneur.2018.01037. eCollection 2018.
9
Significance of CSF NfL and tau in ALS.CSF NfL 和 tau 在 ALS 中的意义。
J Neurol. 2018 Nov;265(11):2633-2645. doi: 10.1007/s00415-018-9043-0. Epub 2018 Sep 5.
10
CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression.脑脊液神经丝轻链升高可预测肌萎缩侧索硬化症的严重程度和进展。
Front Neurol. 2020 Aug 28;11:919. doi: 10.3389/fneur.2020.00919. eCollection 2020.

引用本文的文献

1
Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study.血清神经丝轻链在不同表型肌萎缩侧索硬化症中的变化:一项纵向、多中心研究。
Eur J Neurol. 2024 Sep;31(9):e16379. doi: 10.1111/ene.16379. Epub 2024 Jun 10.
2
MiR-146a in ALS: Contribution to Early Peripheral Nerve Degeneration and Relevance as Disease Biomarker.miR-146a 在肌萎缩侧索硬化症中的作用:对早期周围神经退行性变的贡献及作为疾病生物标志物的相关性。
Int J Mol Sci. 2023 Feb 27;24(5):4610. doi: 10.3390/ijms24054610.

本文引用的文献

1
Early Axonal Dysfunction of the Peripheral Nervous System Influences Disease Progression of ALS: Evidence From Clinical Neuroelectrophysiology.周围神经系统早期轴突功能障碍影响肌萎缩侧索硬化症的疾病进展:来自临床神经电生理学的证据。
Front Neurol. 2021 Feb 11;12:574919. doi: 10.3389/fneur.2021.574919. eCollection 2021.
2
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.CSF 生物标志物在肌萎缩侧索硬化症中的神经退行性变和神经炎症的诊断预后价值及电生理学相关性。
J Neurol. 2020 Jun;267(6):1699-1708. doi: 10.1007/s00415-020-09761-z. Epub 2020 Feb 25.
3
Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis.
诊断时的血清神经丝轻链是肌萎缩侧索硬化症生存的独立预后因素。
Eur J Neurol. 2020 Feb;27(2):251-257. doi: 10.1111/ene.14063. Epub 2019 Sep 18.
4
Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood.脑脊液和血液中神经丝轻链单分子阵列检测法的建立。
Bioanalysis. 2019 Aug;11(15):1405-1418. doi: 10.4155/bio-2019-0163. Epub 2019 Aug 12.
5
Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.血清神经丝轻链在肌萎缩侧索硬化症诊断中的应用。
J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):157-164. doi: 10.1136/jnnp-2018-318704. Epub 2018 Oct 11.
6
Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion.神经丝轻链:肌萎缩侧索硬化症和表型转化的候选生物标志物。
Ann Neurol. 2018 Jul;84(1):130-139. doi: 10.1002/ana.25276. Epub 2018 Aug 16.
7
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies.血清和脑脊液神经丝轻链水平在获得性周围神经病患者中的变化。
J Peripher Nerv Syst. 2018 Sep;23(3):174-177. doi: 10.1111/jns.12279. Epub 2018 Jul 24.
8
Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.血清神经丝轻链水平作为肌萎缩侧索硬化症患者上运动神经元退变的标志物。
Neuropathol Appl Neurobiol. 2019 Apr;45(3):291-304. doi: 10.1111/nan.12511. Epub 2018 Jul 18.
9
Hypermetabolism in ALS is associated with greater functional decline and shorter survival.肌萎缩侧索硬化症中的代谢亢进与更大的功能下降和更短的生存时间相关。
J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1016-1023. doi: 10.1136/jnnp-2017-317887. Epub 2018 Apr 29.
10
Plasma neurofilament light chain concentration in the inherited peripheral neuropathies.遗传性周围神经病中的血浆神经丝轻链浓度。
Neurology. 2018 Feb 6;90(6):e518-e524. doi: 10.1212/WNL.0000000000004932. Epub 2018 Jan 10.